Efficacy and Safety of Belimumab in Primary Sjögren's Syndrome

NCT01008982 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Udine

Collaborators